Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pseudo-Choroidal Melanocytosis in Birdshot Chorioretinitis: A Case Series from a Prospective Cohort.

Ocular immunology and inflammation·2026

Same author

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026

Same author

Incidence of bilateral disease and choroidal neovascularisation in punctate inner choroiditis.

The British journal of ophthalmology·2026

Same author

Evidence and Consensus Based Guidelines for Imaging in Tubercular Choroiditis. Multimodal imaging in Uveitis (MUV) Taskforce: Report 17.

Ophthalmology. Retina·2026

Same author

Toxoplasmosis meets the World Health Organization criteria for a neglected tropical disease.

PLoS neglected tropical diseases·2026

Same author

Novel PPOX Mutation With Ocular Involvement in Variegate Porphyria: Case Report and Literature Review.

Cornea·2026

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Recent advances in mucous membrane pemphigoid.

Ebenezer Daniel¹, Jennifer E Thorne

¹Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.

Current Opinion in Ophthalmology

|June 12, 2008

Summary

This summary is machine-generated.

Mucous membrane pemphigoid is a serious condition with a 15-20% risk of eye complications. Diagnosis requires biopsy and direct immunofluorescence, while treatment involves immunosuppressants with varied outcomes.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Related Experiment Videos

Last Updated: Jul 4, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Area of Science:

Dermatology
Immunology

Background:

Mucous membrane pemphigoid (MMP) is a chronic autoimmune blistering disease.
It can lead to significant morbidity, including sight-threatening ocular complications.

Purpose of the Study:

To review the English literature on mucous membrane pemphigoid published between 2006 and 2007.
To summarize current understanding of diagnosis, risk factors, and treatment.

Main Methods:

Literature review of articles published from 2006-2007.
Analysis of diagnostic methods, particularly biopsy and direct immunofluorescence.
Review of treatment modalities, including immunosuppressive drugs and biologic therapy.

Main Results:

An estimated 15-20% of patients with oral-only MMP develop ocular disease within 5 years.
Direct immunofluorescence is crucial for diagnosis, as histopathology alone lacks specificity.
Autoantibodies, particularly IgG and IgG4, are common findings in direct immunofluorescence.
Treatment with immunosuppressants and intravenous immunoglobulin shows mixed results, with much data from case series.

Conclusions:

Mucous membrane pemphigoid remains a potentially life- and sight-threatening disease.
Therapeutic outcomes for MMP are variable, though some patients show clear benefits.
Ongoing evolution in the understanding and treatment of MMP, including specific drug categories, is noted.